Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 02, 2018 01:01 ET | Source: Ablynx NV

PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")

REGULATED INFORMATION GHENT, Belgium, 2 February 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the...
February 02, 2018 01:01 ET | Source: Ablynx NV

OPENBAARMAKING IN OVEREENSTEMMING MET ARTIKEL 14 VAN DE BELGISCHE WET VAN 2 MEI 2007 BETREFFENDE DE OPENBAARMAKING VAN BELANGRIJKE DEELNEMINGEN (DE "TRANSPARANTIEWET")

GEREGLEMENTEERDE INFORMATIE GENT, België, 2 februari 2018 - Ablynx [Euronext Brussels en Nasdaq: ABLX] maakte vandaag bekend, in overeenstemming met artikel 14 van de Belgische wet van 2 mei 2007...
January 29, 2018 02:20 ET | Source: Ablynx NV

SANOFI TO ACQUIRE ABLYNX FOR €3.9 BILLION

Regulated information - inside information Strengthens Sanofi's R&D strategy with innovative Nanobody® technology platform Expands growing rare blood disorders franchise with Ablynx's...
January 29, 2018 02:20 ET | Source: Ablynx NV

SANOFI NEEMT ABLYNX OVER VOOR €3,9 MILJARD

Gereglementeerde informatie - voorwetenschap Versterking van Sanofi's O&O strategie met het innovatief Nanobody® technologisch platform Uitbreiding van de toenemende franchise voor...
January 24, 2018 01:01 ET | Source: Ablynx NV

ABLYNX APPOINTS DR ROBERT FRIESEN AS CHIEF SCIENTIFIC OFFICER

GHENT, Belgium, 24 January 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced the appointment of Robert Friesen, PhD, as Chief Scientific Officer (CSO), effective 1 March 2018. Dr...
January 24, 2018 01:01 ET | Source: Ablynx NV

ABLYNX BENOEMT DR ROBERT FRIESEN ALS CHIEF SCIENTIFIC OFFICER

GENT, België, 24 januari 2018 - Ablynx NV [Euronext Brussels en Nasdaq: ABLX] deelde vandaag de benoeming mee van Robert Friesen, PhD, als Chief Scientific Officer (CSO), met ingang 1 maart 2018. Dr...
January 22, 2018 01:02 ET | Source: Ablynx NV

ABLYNX KONDIGT UITOEFENING WARRANTS AAN EN CONVERSIE VAN OBLIGATIES

GEREGLEMENTEERDE INFORMATIE GENT, België, 22 januari 2018 - Ablynx [Euronext Brussels en Nasdaq: ABLX] kondigde vandaag aan, in overeenstemming met titel II van de Wet van 2 mei 2007 en het...
January 22, 2018 01:02 ET | Source: Ablynx NV

ABLYNX ANNOUNCES WARRANTS EXERCISE AND CONVERSION OF BONDS

REGULATED INFORMATION GHENT, Belgium, 22 January 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in conformity with Title II of the Law of 2 May 2007 and the Royal Decree of...
January 18, 2018 01:11 ET | Source: Ablynx NV

PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")

REGULATED INFORMATION GHENT, Belgium, 18 January 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the...
January 18, 2018 01:11 ET | Source: Ablynx NV

OPENBAARMAKING IN OVEREENSTEMMING MET ARTIKEL 14 VAN DE BELGISCHE WET VAN 2 MEI 2007 BETREFFENDE DE OPENBAARMAKING VAN BELANGRIJKE DEELNEMINGEN (DE "TRANSPARANTIEWET")

GEREGLEMENTEERDE INFORMATIE GENT, België, 18 januari 2018 - Ablynx [Euronext Brussels en Nasdaq: ABLX] maakte vandaag bekend, in overeenstemming met artikel 14 van de Belgische wet van 2 mei 2007...